Thursday, February 06, 2020 1:43:35 PM
This is Jon Pevzner of Connectyx. There is absolutely nothing going on with the company that triggered this activity starting in December. I have no idea how it went from grey to pink as there is no record of a 211 being filed with FINRA. I'm looking into the circumstances behind this PR as it looks like a Chinese hack to me.
My correct email is jon@connectyx.com. I just responded to several of you that emailed me in the last hour.
It was correctly stated a couple of weeks ago that we are trying to sell the shell and that fact remains true.
My correct email is jon@connectyx.com. I just responded to several of you that emailed me in the last hour.
It was correctly stated a couple of weeks ago that we are trying to sell the shell and that fact remains true.
Recent CUBT News
- Curative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research Agreement • GlobeNewswire Inc. • 05/07/2026 11:00:00 AM
- Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic Therapy • GlobeNewswire Inc. • 04/15/2026 12:08:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:05:00 PM
- Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Curative Biotechnology Announces Canadian Patent Allowance • GlobeNewswire Inc. • 01/23/2026 01:45:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 12/22/2025 06:40:01 PM
- Curative Biotechnology, Inc. Announces Letter to Shareholders • GlobeNewswire Inc. • 11/18/2025 01:15:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/01/2025 08:07:47 PM
